Nearly Half of Studied COPD Patients Suffer Breathlessness

Nearly Half of Studied COPD Patients Suffer Breathlessness

BreathlessnessShortness of breath, otherwise known as dyspnoea or “air hunger,” is a common symptom of chronic obstructive pulmonary disease (COPD). It is a serious problem that should not be ignored, and a group of researchers from GlaxoSmithKline R&D in the United States and United Kingdom determined that nearly half of COPD patients may suffer from moderate-to-severe dyspnoea. As a promoter and provider of information concerning COPD, it is possible that GlaxoSmithKline may spread the word about dyspnoea on the newly relaunched website.

A multitude of factors contributing to dyspnoea were analyzed for a sample of 49,438 patients from the Clinical Practice Research Datalink in the researchers’ study, “Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care.” A large majority (40,425) of patients had some form of breathlessness as determined by the Medical Research Council dyspnoea scale, where a score of 5 represents the most severe case of breathlessness.

Approximately half (46%) of patients had an MRC score greater than three, placing them in the category of moderate-to-severe dyspnoea. Although a high degree of airflow limitation was associated with increased breathlessness, 32% of patients with mild airflow obstruction experienced breathlessness. Other contributing factors included female gender, old age, obesity, previous moderate-to-severe COPD exacerbations, and the need to see a general practitioner frequently.

Patients with dyspnoea of all severities, even mild, were at a higher risk for exacerbations and increased disease severity during follow-ups. New, unrelated research might be able to help those patients who suffer from exacerbations: as reported by Lung Disease News, prophylaxis therapy may reduce the occurrence of exacerbations in COPD patients. Overall, in this study breathlessness indicated poorer outcomes for COPD patients.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published.